Abstract: Bone tissue is the hardest and most dynamic connective tissue in the human body, and its integrity is essential for maintaining both mechanical support and physiological functions. However, with the aging population, the incidence of fractures, osteoporosis, and bone defects has risen significantly, severely impairing patients’ quality of life and creating a substantial social burden. Although autologous or allogeneic bone grafts and metallic or non-metallic implants can partially restore bone defects, their long-term efficacy is constrained by donor shortages, immune rejection, and limited regenerative capacity. Consequently, the development of efficient, precise, and biomimetic bone regeneration strategies is of great importance. In recent years, biomimetic nanoparticles have shown unique advantages in mimicking the bone microenvironment, delivering bioactive factors, and modulating cellular behavior due to their tunable structures and functions. This review summarizes the structural composition of bone tissue and its repair processes, highlights biomimetic nanoparticle construction strategies based on cell membranes, exosomes, proteins, and peptides, and discusses their roles in osteogenesis, mineralization, immune regulation, and neurovascular development. Finally, it explores their clinical translation prospects and associated challenges. Keywords: biomimetic nanoparticles, bone regeneration, exosomes, targeting, tissue engineering
Wang et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: